Cargando…
DNase to the Rescue! Clearing Mitochondrial DNA May Have NET Benefits in Lung Transplantation
Autores principales: | Juvet, Stephen, Martinu, Tereza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055693/ https://www.ncbi.nlm.nih.gov/pubmed/31726015 http://dx.doi.org/10.1165/rcmb.2019-0390ED |
Ejemplares similares
-
Sequential broncho-alveolar lavages reflect distinct pulmonary compartments: clinical and research implications in lung transplantation
por: Levy, Liran, et al.
Publicado: (2018) -
IL‐6 receptor blockade for allograft dysfunction after lung transplantation in a patient with COPA syndrome
por: Riddell, Peter, et al.
Publicado: (2021) -
Targeting NETs using dual-active DNase1 variants
por: Englert, Hanna, et al.
Publicado: (2023) -
Bladder cancer patients have increased NETosis and impaired DNaseI-mediated NET degradation that can be therapeutically restored in vitro
por: Herranz, Raquel, et al.
Publicado: (2023) -
The Biology of Cell-free DNA Fragmentation and the Roles of DNASE1, DNASE1L3, and DFFB
por: Han, Diana S.C., et al.
Publicado: (2020)